Lung cancer treatment in Europe ahead of UK

Lung cancer treatment in the UK is falling far behind that of the rest of Europe, figures released by the NHS Information Centre and the Royal College of Physicians has revealed.

The organisation compared statistics from the UK and compared them with data from the rest of Europe to determine any disparity between performances in lung cancer treatment.

Care, diagnosis and treatment were the main areas where the UK was found to be offering a service that was inferior to other European countries.

NHS Information Centre chief executive Tim Straughan, commented: "While there have been overall improvements in care since the previous audit in 2006, there’s still a wide variation between hospitals which cannot be explained on the basis of differing patient profiles alone."

He added that the trusts now have to analyse the data that shows where there may be room for improvement and take action accordingly.

An aggressive childhood lung cancer that is extremely rare is thought to be caused by a gene DICER1, which has already been connected to cancer development, researchers in the US have found.

Comment on this page »


Latest news

AXA PPP healthcare win at UK Customer Experience awards 2015

David Mobbs retires as CEO of Nuffield Health

King's victorious at World Transplant Games

Lung cancer treatment in Europe ahead of UK
Connect with us on:

This site compiles with the HONcode standard for trustworthy health information